EE456 Cost-Effectiveness of Tenofovir Alafenamide (TAF) for Treatment of Chronic Hepatitis B in Taiwan

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.701
https://www.valueinhealthjournal.com/article/S1098-3015(22)02905-9/fulltext
Title : EE456 Cost-Effectiveness of Tenofovir Alafenamide (TAF) for Treatment of Chronic Hepatitis B in Taiwan
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02905-9&doi=10.1016/j.jval.2022.09.701
First page :
Section Title :
Open access? : No
Section Order : 10238
Categories :
Tags :
Regions :
ViH Article Tags :